DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cerubidine (Daunorubicin) - Renal Failure - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Renal Failure (6)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cerubidine (Daunorubicin) where reactions include renal failure. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Cerubidine side effects in 56 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-24

Patient: 56 year old male

Reactions: Cytolytic Hepatitis, Coagulation Factor V Level Decreased, Renal Failure, Dialysis, Venoocclusive Liver Disease, Platelet Count Decreased, Febrile Bone Marrow Aplasia, Septic Shock

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Cerubidine



Possible Cerubidine side effects in 56 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-24

Patient: 56 year old male

Reactions: White Blood Cell Count Decreased, Blood Alkaline Phosphatase Increased, Alanine Aminotransferase Increased, Coagulation Factor V Level Decreased, Venoocclusive Disease, Renal Failure, Gamma-Glutamyltransferase Increased, Dialysis, Aspartate Aminotransferase Increased, Febrile Bone Marrow Aplasia, Platelet Count Decreased, Klebsiella Test Positive, Septic Shock, Immunosuppression

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Cerubidine



Possible Cerubidine side effects in 56 year old male

Reported by a physician from France on 2011-10-24

Patient: 56 year old male

Reactions: Blood Alkaline Phosphatase Increased, Alanine Aminotransferase Increased, Coagulation Factor V Level Decreased, Renal Failure, Gamma-Glutamyltransferase Increased, Dialysis, Aspartate Aminotransferase Increased, Venoocclusive Liver Disease, Febrile Bone Marrow Aplasia, Klebsiella Test Positive, Septic Shock, Immunosuppression

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Gemtuzumab Ozogamicin (Gemtuzumab Ozogamicin)
    Dosage: 6 mg/m2, 1x/day, intravenous
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-08-16
    End date: 2010-08-16

Cytarabine
    Dosage: 200 mg/m2, 1x/day, intravenous
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-08-13
    End date: 2010-08-19

Cerubidine
    Dosage: 60 mg/m2, 1x/day, intravenous
    Indication: Acute Myeloid Leukaemia
    Start date: 2010-08-13
    End date: 2010-08-15



Possible Cerubidine side effects in 56 year old male

Reported by a physician from France on 2011-10-24

Patient: 56 year old male

Reactions: Renal Failure, Dialysis, Venoocclusive Liver Disease, Cytolytic Hepatitis, Febrile Bone Marrow Aplasia, Septic Shock

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Cytarabine
    Dosage: 200 mg/m2, 1x/day, intravenous
    Indication: Leukaemia
    Start date: 2010-08-13
    End date: 2010-08-19

Gemtuzumab Ozogamicin (Gemtuzumab Ozogamicin)
    Dosage: 6 mg/m2, 1x/day, intravenous
    Indication: Acute Leukaemia
    Start date: 2010-08-16
    End date: 2010-08-16

Cerubidine
    Dosage: 60 mg/m2, 1x/day, intravenous
    Indication: Acute Leukaemia
    Start date: 2010-08-13
    End date: 2010-08-15

Other drugs received by patient: Amlodipine Besylate; Valsartan and Hydrochlorothiazide



Possible Cerubidine side effects in 60 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-14

Patient: 60 year old female

Reactions: Renal Failure, Disseminated Intravascular Coagulation, Cytolytic Hepatitis

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cerubidine



Possible Cerubidine side effects in 60 year old female

Reported by a physician from France on 2011-10-14

Patient: 60 year old female

Reactions: Renal Failure, Disseminated Intravascular Coagulation, Cytolytic Hepatitis

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cytarabine
    Dosage: 1000 mg/m2, 2x/day, intravenous
    Indication: Leukaemia
    Start date: 2010-04-21
    End date: 2010-04-22

Cerubidine
    Dosage: 60 mg/m2, 1x/day, intravenous
    Indication: Leukaemia
    Start date: 2010-04-21
    End date: 2010-04-23

Ambisome
    Dosage: 180 mg, 1x/day, intravenous
    Start date: 2010-04-21
    End date: 2010-04-22

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017